by Truveta staff | Jan 18, 2024 | Data
Crohn’s disease, a complex chronic inflammatory disorder of the GI tract, affects approximately 780,000 Americans with an estimated 33,000 new cases diagnosed each year. Crohn’s, along with ulcerative colitis, are the two major forms of inflammatory bowel disease...
by Terry Myerson, CEO | Nov 20, 2023 | Culture
Eight months ago, we had a fateful meeting… “We have some incredibly diverse and engaged customers doing innovative work that would benefit from meeting and learning from each other…. Our solutions are getting more powerful, and we want to get the word out… We want to...
by Truveta staff | Nov 1, 2023 | Data
October was a whirlwind month for Truveta, marked by participation in various conferences across the United States. In the span of less than 10 days, Truveta experts and customers presented at four different events, showcasing how Truveta Data is being used to enable...
by Truveta staff | Oct 26, 2023 | Data
Hidden under the surface of daily life, a disease often referred to as a “silent killer” is slowly taking hold over millions of Americans. While approximately 4.5M US adults have received a diagnosis of liver disease, a far larger yet largely unaware group is treading...
by Truveta staff | Oct 2, 2023 | Data
In the realm of medtech innovation, the margin for error is slim. Upwards of 90% of funding for an early-stage company may be allocated to engineering and clinical costs, making it essential for leaders to de-risk their clinical programs. Having access to a...